The NMDA and TRPV1 receptors that are expressed in sensory neurons have been independently demonstrated to play important roles in peripheral pain mechanisms. In the present study, we investigated whether the 2 receptor-channel systems form a functional complex that provides the basis for the development of mechanical hyperalgesia. In the masseter muscle, direct application of NMDA induced a timedependent increase in mechanical sensitivity, which was significantly blocked when the muscle was pretreated with a specific TRPV1 antagonist, AMG9810. The NR1 subunit of the NMDA receptor and TRPV1 were coexpressed in 32% of masseter afferents in trigeminal ganglia (TG). Furthermore, NR1 and NR2B formed protein-protein complexes with TRPV1 in TG as demonstrated by coimmunoprecipitation experiments. Calcium imaging analyses further corroborated that NMDA and TRPV1 receptors functionally interact. In TG culture, application of NMDA resulted in phosphorylation of serine, but not threonine or tyrosine, residues of TRPV1 in a time course similar to that of the development of NMDA-induced mechanical hyperalgesia. The NMDA-induced phosphorylation was significantly attenuated by CaMKII and PKC inhibitors, but not by a PKA inhibitor. Consistent with the biochemical data, the NMDA-induced mechanical hyperalgesia was also effectively blocked when the muscle was pretreated with a CaMKII or PKC inhibitor. Thus, NMDA receptors and TRPV1 functionally interact via CaMKII and PKC signaling cascades and contribute to mechanical hyperalgesia. These data offer novel mechanisms by which 2 ligandgated channels in sensory neurons interact and reinforce the notion that TRPV1 functions as a signal integrator under pathological conditions. Ó
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Introduction
There is a large body of evidence demonstrating that endogenous release of glutamate in peripheral tissue after injury or inflammation can exacerbate pain conditions and modulate functional properties of nociceptors in skin, muscles, and joints [33, 46, 58] . A higher level of endogenous glutamate in the masseter muscle of temporomandibular disorder patients relative to healthy subjects further suggests the involvement of peripheral glutamate receptors (gluRs) in persistent muscle pain conditions [8] . Human and animal studies have consistently demonstrated the involvement of gluRs such as the NMDA receptor (NMDAR) and the metabotropic glutamate receptor 5 (mGluR5) in trigeminal sensory neurons in acute pain and mechanical hyperalgesia arising from orofacial muscle tissue [6, 36, 54, 63] . However, the cellular mechanisms by which these gluRs lead to heightened mechanical sensitivity in deep craniofacial tissue are still unknown.
Mice lacking functional TRPV1 display impaired behavioral responses to noxious heat stimuli applied to cutaneous tissue while responses to noxious mechanical stimuli remain intact [9, 10] . More recent studies, however, indicate that TRPV1 also contributes to the development of mechanical hyperalgesia. TRPV1 antagonists effectively reduce mechanical hyperalgesia in rats with spinal nerve ligation [13, 14] as well as complete Freund's adjuvant (CFA)-induced mechanical hyperalgesia [19, 24, 50] . Aside from cutaneous tissue, TRPV1 has been suggested to play an important role in mechanical sensation in deep tissue such as the colon [29] . In muscle tissue, the direct injection of capsaicin significantly lowers mechanical thresholds in both humans and rats [1, 56] , and the blockade of TRPV1 attenuates mechanical hyperalgesia resulting from eccentric muscle contraction [17] . 
